{"id":61878,"date":"2025-09-17T07:03:48","date_gmt":"2025-09-17T05:03:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/"},"modified":"2025-09-17T07:03:48","modified_gmt":"2025-09-17T05:03:48","slug":"overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/","title":{"rendered":"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform"},"content":{"rendered":"
\n

\nAhead of receipt of anticipated CE Mark, European customers can begin requesting DaVitri to expand patient access to high-quality IVF<\/i><\/p>\n

MADRID–(BUSINESS WIRE)–Overture Life, the innovator modernizing IVF to optimize reproductive freedom, today announced the launch of its European preorder waitlist for DaVitri, the world\u2019s first automated vitrification platform. The waitlist ensures in vitro fertilization (IVF) facilities will be among the first in Europe to harness DaVitri to reduce manual workloads for their embryologists while eliminating operator variability, thereby providing patients with faster, more consistent procedures.<\/p>\n

<\/a>
<\/a><\/p>\n

\nAs infertility rates spike worldwide, interest in egg freezing continues to rise while the infrastructure to support it lags behind. Egg freezing requires vitrification, typically a time-intensive, manual process vulnerable to human error that can only be performed by extensively trained embryologists. This has resulted in variability in egg and embryo survival rates that directly impact IVF success, as well as significant access issues caused by the throughput bottleneck.<\/p>\n

\nDaVitri automates egg vitrification, delivering consistent gold-standard results regardless of operator experience. The platform increases efficiency and throughput while maximizing the likelihood that preserved eggs or embryos remain viable for future use.<\/p>\n

\n\u201cAs demand for fertility preservation grows across Europe, IVF centers face mounting pressure on staff and resources,\u201d said Hans Gangeskar, CEO of Overture Life. \u201cDaVitri brings modernization to IVF by ensuring every egg and embryo has the best possible chance of survival, no matter where it\u2019s preserved. With the preorder waitlist, we\u2019re enabling clinics to plan ahead, optimally allocate resources, and avoid patient delays, all without compromising consistency or control.\u201d<\/p>\n

\nDaVitri is already marketed in six Central and South American countries. By joining the preorder waitlist, European IVF clinics can secure initial access to DaVitri upon full commercial rollout and give patients the benefits of automated vitrification technology months or even years sooner. Automated protocols replace operator-dependent steps, ensuring equal quality of treatment in both major urban hospitals and smaller regional centers.<\/p>\n

\nWith DaVitri, clinics can accommodate more patients without long wait times, helping people begin treatment sooner. The preorder program ensures units are shipped where they are needed most, backed by early-bird training, onboarding support, and exclusive clinical performance updates so providers are ready the moment the device arrives.<\/p>\n

\nClinics can reserve their place on the European waitlist here: https:\/\/overture.life\/waitlist<\/a><\/p>\n

\nAbout Overture Life<\/b><\/p>\n

\nOverture Life integrates engineering, reproductive medicine, and regulatory-grade validation to modernize embryology lab procedures, particularly egg freezing and embryo handling, in ways that lower repeated cycles, increase throughput, and reduce the overall cost of IVF. With R&D in Spain and active U.S. operations, including a CLIA-licensed laboratory for non-invasive embryo selection, Overture unites robotics, analytics, and clinical rigor to deliver tools that clinics and patients can trust. The company\u2019s DaVitri platform aims to boost reliability and consistency in IVF, giving women and families worldwide more control over their fertility timelines. Overture\u2019s backers include Overwater Ventures, GV, Khosla Ventures, Octopus Ventures and others committed to advancing the future of fertility.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact<\/b>
overture@consortpartners.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Ahead of receipt of anticipated CE Mark, European customers can begin requesting DaVitri to expand patient access to high-quality IVF MADRID–(BUSINESS WIRE)–Overture Life, the innovator modernizing IVF to optimize reproductive freedom, today announced the launch of its European preorder waitlist for DaVitri, the world\u2019s first automated vitrification platform. The waitlist ensures in vitro fertilization (IVF) … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61878","6":"format-standard","7":"category-industry"},"yoast_head":"\nOverture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Ahead of receipt of anticipated CE Mark, European customers can begin requesting DaVitri to expand patient access to high-quality IVF MADRID–(BUSINESS WIRE)–Overture Life, the innovator modernizing IVF to optimize reproductive freedom, today announced the launch of its European preorder waitlist for DaVitri, the world\u2019s first automated vitrification platform. The waitlist ensures in vitro fertilization (IVF) ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-17T05:03:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250916238720\/en\/2582347\/22\/Overture_Life_Logo_for_Business_Wire.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform\",\"datePublished\":\"2025-09-17T05:03:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/\"},\"wordCount\":524,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250916238720\\\/en\\\/2582347\\\/22\\\/Overture_Life_Logo_for_Business_Wire.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/\",\"name\":\"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250916238720\\\/en\\\/2582347\\\/22\\\/Overture_Life_Logo_for_Business_Wire.jpg\",\"datePublished\":\"2025-09-17T05:03:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250916238720\\\/en\\\/2582347\\\/22\\\/Overture_Life_Logo_for_Business_Wire.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250916238720\\\/en\\\/2582347\\\/22\\\/Overture_Life_Logo_for_Business_Wire.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/","og_locale":"en_US","og_type":"article","og_title":"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform - Pharma Trend","og_description":"Ahead of receipt of anticipated CE Mark, European customers can begin requesting DaVitri to expand patient access to high-quality IVF MADRID–(BUSINESS WIRE)–Overture Life, the innovator modernizing IVF to optimize reproductive freedom, today announced the launch of its European preorder waitlist for DaVitri, the world\u2019s first automated vitrification platform. The waitlist ensures in vitro fertilization (IVF) ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-17T05:03:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250916238720\/en\/2582347\/22\/Overture_Life_Logo_for_Business_Wire.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform","datePublished":"2025-09-17T05:03:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/"},"wordCount":524,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250916238720\/en\/2582347\/22\/Overture_Life_Logo_for_Business_Wire.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/","url":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/","name":"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250916238720\/en\/2582347\/22\/Overture_Life_Logo_for_Business_Wire.jpg","datePublished":"2025-09-17T05:03:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250916238720\/en\/2582347\/22\/Overture_Life_Logo_for_Business_Wire.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250916238720\/en\/2582347\/22\/Overture_Life_Logo_for_Business_Wire.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/overture-life-launches-european-preorder-waitlist-for-davitri-the-worlds-first-microfluidics-based-automated-vitrification-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Overture Life Launches European Preorder Waitlist for DaVitri, the World\u2019s First Microfluidics-Based Automated Vitrification Platform"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61878"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61878\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}